Educational Activities Archives

Substance Use Disorders in Older Adults is a growing problem not only in the United States but throughout the developed world. The Baby Boomer generation, born between 1946 and 1964, is turning 62-80 years old this year. This group is presenting with more Substance Use Disorders and need for substance use treatment now. The use of an artificial cut off age of 65 years as the definition of elderly or old is arbitrary, and this will be discussed. The course will look at the prevalence, screening and treatment of non-medical use of prescription drugs and illicit opioids, as well as use of tobacco, alcohol, stimulants and cocaine, marijuana, and non-opioid sedative hypnotic agents. There are interactive questions throughout the course to help digest and discuss the information presented.

Polysubstance use has been more the rule than the exception in treating substance use problems. The problem can complicate treatment and add significantly to the morbidity of the disease. This webinar will review the co-occurrence of various drug use disorders and how to more effectively address the patient and treat the disorder.

Motivational interviewing (MI) is an evidence-based approach to guide and enhance conversations when working with patients to promote positive behavior change. Originally developed in the context of treating substance use disorders, MI is a collaborative method of communication that pays particular attention to the language of change. MI helps to strengthen intrinsic motivation for change by exploring the patient’s own reasons for change by communicating the spirit of acceptance, partnership, empowerment, and compassion. This educational activity will introduce key MI concepts, including the four tasks, the spirit of MI, and skills for evoking change talk.

Other substance use disorders can often co-occur with opioid use disorder (OUD). These can include benzodiazepines and other tranquilizers, cocaine and stimulants, and cannabis. Alcohol and nicotine are also considered commonly used substances alongside opioids. In this educational activity, these other substances will be reviewed leading to a discussion of principles of diagnosis and evaluation of treatment for each substance by themselves, and in the context of OUD.

Co-occurring psychiatric conditions are frequently seen in patients with substance use disorders. Clinicians should be alert to the signs and symptoms of common psychiatric disorders and should understand how to distinguish independent psychiatric disorders from substance-induced disorders. Depressive disorders and anxiety disorders, including post-traumatic stress disorder, are the most common co-occurring conditions, though ADHD is often encountered across the range of substance use disorders. Substance use disorder patients with co-occurring psychiatric disorders will respond to most standard psychological and pharmacological treatments for these psychiatric conditions, though clinicians should avoid the use of scheduled medications and must always focus on sobriety as a primary treatment goal. Treatment that integrates addiction and psychiatric care is the most effective.

Recent attention has turned to opioid use disorder (OUD) and other substance use disorders (SUDs) as significant and growing health concerns among older adults. Biopsychosocial complications that develop with age, including medical comorbidities and cognitive impairments, contribute to some of the adverse interactions between substance misuse and the aging brain. This webinar will focus on how professionals can effectively work at the intersection of aging, mental health, and substance use, with a specific emphasis on opioid use disorder. Participants will learn practical strategies for assessing, diagnosing, treating, and supporting older clients with OUD or other SUDs, and will be empowered to offer compassionate, evidence-informed, and age-responsive care.